JPS61221120A - 外用医薬部材 - Google Patents
外用医薬部材Info
- Publication number
- JPS61221120A JPS61221120A JP60064174A JP6417485A JPS61221120A JP S61221120 A JPS61221120 A JP S61221120A JP 60064174 A JP60064174 A JP 60064174A JP 6417485 A JP6417485 A JP 6417485A JP S61221120 A JPS61221120 A JP S61221120A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- skin
- compound
- composition
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60064174A JPS61221120A (ja) | 1985-03-28 | 1985-03-28 | 外用医薬部材 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60064174A JPS61221120A (ja) | 1985-03-28 | 1985-03-28 | 外用医薬部材 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61221120A true JPS61221120A (ja) | 1986-10-01 |
JPH0529006B2 JPH0529006B2 (es) | 1993-04-28 |
Family
ID=13250434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60064174A Granted JPS61221120A (ja) | 1985-03-28 | 1985-03-28 | 外用医薬部材 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61221120A (es) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
US6344218B1 (en) | 1998-11-23 | 2002-02-05 | The Procter & Gamble Company | Skin deodorizing and santizing compositions |
WO2002032459A3 (en) * | 2000-10-17 | 2002-08-15 | Massachusetts Inst Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
US9827324B2 (en) | 2003-12-31 | 2017-11-28 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9065093B2 (en) | 2011-04-07 | 2015-06-23 | Massachusetts Institute Of Technology | Controlled porosity in electrodes |
-
1985
- 1985-03-28 JP JP60064174A patent/JPS61221120A/ja active Granted
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2307176A (en) * | 1995-11-15 | 1997-05-21 | Todd Selwyn Everest | Anti-inflammatory clathrating agents for topical use |
US6344218B1 (en) | 1998-11-23 | 2002-02-05 | The Procter & Gamble Company | Skin deodorizing and santizing compositions |
WO2002032459A3 (en) * | 2000-10-17 | 2002-08-15 | Massachusetts Inst Technology | Method of increasing the efficacy of antibiotics by complexing with cyclodextrins |
US9827324B2 (en) | 2003-12-31 | 2017-11-28 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US10159752B2 (en) | 2003-12-31 | 2018-12-25 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US10207008B2 (en) | 2003-12-31 | 2019-02-19 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US10799599B2 (en) | 2003-12-31 | 2020-10-13 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
Also Published As
Publication number | Publication date |
---|---|
JPH0529006B2 (es) | 1993-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5830505A (en) | Active ingredient patch | |
FI107708B (fi) | Menetelmä lääkkeenantolaitteessa käytettävän matriisin valmistamiseksi | |
EP0782861A1 (en) | Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation | |
JP2587365B2 (ja) | 経皮吸収性製剤の製法 | |
JPH066534B2 (ja) | 経皮吸収貼付剤 | |
JPS63313723A (ja) | 外用貼付剤 | |
JP2688778B2 (ja) | 疾患治療用貼付剤 | |
JPS6314685B2 (es) | ||
JPS61221120A (ja) | 外用医薬部材 | |
JPH0459296B2 (es) | ||
JPS61267510A (ja) | 外用医薬部材 | |
JPH0152362B2 (es) | ||
JPH02149514A (ja) | 医薬部材 | |
JPH0238569B2 (es) | ||
JPH0818975B2 (ja) | 疾患治療用貼付剤 | |
JP2565334B2 (ja) | 薬剤放出性可変型貼付製剤 | |
JPH078785B2 (ja) | 経皮吸収性製剤の製造方法 | |
JPS596286B2 (ja) | テ−プ製剤 | |
JPS63270060A (ja) | 抗菌性粘着部材 | |
JPH05139961A (ja) | 医療用感圧性接着剤及びこれを用いた医療用製剤 | |
JPH05131022A (ja) | 外用医薬製剤 | |
JPS6059209B2 (ja) | 複合製剤 | |
JPS61267512A (ja) | 積層構造物 | |
JPH05186371A (ja) | 経皮吸収製剤 | |
US8586080B1 (en) | Inhibiting crystallization of steroidal hormones in transdermal delivery systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |